Notizie
Iran – A new randomized clinical trial published in Dermatologic Therapy has found that intramuscular pantothenic acid ...
Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...
Cancer drugs that have been used for two decades were retooled until they were able to eliminate aggressive tumors in a ...
The company's shares are down 18% over the trailing-12-month period due to a combination of headwinds. While that's not the ...
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) announced that the results of its Phase 3 IMPALA-2 clinical trial for molgramostim ...
13 h
TipRanks on MSNAbbVie’s New Phase 2 Trial: A Potential Game-Changer in Cancer Treatment?
Abbvie (($ABBV)) announced an update on their ongoing clinical study. Study Overview: AbbVie is spearheading a Phase 2 ...
Welcome to this week's edition of The Targeted Pulse, your clinical-focused wrap-up of the most impactful news and research ...
A virus that infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy, say researchers at ...
Unable to find treatment, parents of children with Infantile Neuroaxonal Dystrophy are taking it upon themselves to fund ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
The project, valued at Rs 10 crore and expected to be completed within 12 months, also includes carrying out quality and ...
Alcuni risultati sono stati nascosti perché potrebbero non essere accessibili.
Mostra risultati inaccessibili